KoBioLabs
KoBioLabs, Inc. is a biotechnology company based in Seoul, South Korea, specializing in microbiome therapeutics. The company focuses on developing innovative treatments for a range of health conditions, including metabolic, immune, and neurological diseases. Through its research efforts, KoBioLabs aims to harness the potential of the microbiome to create effective medicinal solutions that address these critical areas of human health.
1 past transactions
WeBiom
Venture Round in 2022
WeBiom is a company focused on developing and supplying probiotic-based health supplements, specifically utilizing microbiome lactobacilli. The company aims to promote inner beauty and overall wellness through innovative products that harness the benefits of microbiome technology. By emphasizing the importance of a healthy microbiome, WeBiom seeks to empower consumers to enhance their health and well-being, ultimately contributing to a healthier lifestyle.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.